Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBT Margin: 2013-2018

Historic EBT Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to 326.71%.

  • Armata Pharmaceuticals' EBT Margin rose 1208671.00% to 326.71% in Q4 2018 from the same period last year, while for Dec 2018 it was 2,231.32%, marking a year-over-year increase of 1069828.00%. This contributed to the annual value of 955.06% for FY2024, which is 323236.00% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported EBT Margin of 326.71% as of Q4 2018, which was down 63.80% from 902.61% recorded in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' EBT Margin peaked at 10,980.68% during Q2 2018, and registered a low of -45,709.09% during Q4 2016.
  • In the last 3 years, Armata Pharmaceuticals' EBT Margin had a median value of -4,262.26% in 2016 and averaged -7,814.68%.
  • In the last 5 years, Armata Pharmaceuticals' EBT Margin surged by 7,325,469bps in 2014 and then crashed by 4,341,222bps in 2016.
  • Over the past 5 years, Armata Pharmaceuticals' EBT Margin (Quarterly) stood at -2,571.29% in 2014, then skyrocketed by 27,441bps to -2,296.88% in 2015, then crashed by 4,341,222bps to -45,709.09% in 2016, then spiked by 3,394,909bps to -11,760.00% in 2017, then skyrocketed by 1,208,671bps to 326.71% in 2018.
  • Its last three reported values are 326.71% in Q4 2018, 902.61% for Q3 2018, and 10,980.68% during Q2 2018.